Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-13

Clinical Trial Update: Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing vonoprazan-based triple therapy (with vitamin D or probiotics) versus a proton pump inhibitor–based triple therapy for Helicoba…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Proton Pump Inhibitor (proton pump inhibitor)
  • Vonoprazan (vonoprazan)

Snippet

Sponsor: Tanta University | Conditions: HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection | Phase 2 | Status: RECRUITING